Literature DB >> 30776077

A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections.

Nathan Kuppermann1, Peter S Dayan2, Deborah A Levine3, Melissa Vitale4, Leah Tzimenatos5, Michael G Tunik3, Mary Saunders6,7, Richard M Ruddy8,9, Genie Roosevelt10, Alexander J Rogers11, Elizabeth C Powell12, Lise E Nigrovic13, Jared Muenzer14,15, James G Linakis16,17, Kathleen Grisanti18, David M Jaffe14, John D Hoyle19,20, Richard Greenberg21, Rajender Gattu22, Andrea T Cruz23, Ellen F Crain24, Daniel M Cohen25,26, Anne Brayer27, Dominic Borgialli28,29, Bema Bonsu25,26, Lorin Browne30, Stephen Blumberg24, Jonathan E Bennett31, Shireen M Atabaki32, Jennifer Anders33, Elizabeth R Alpern34,35, Benjamin Miller36, T Charles Casper36, J Michael Dean36, Octavio Ramilo26,37, Prashant Mahajan38,39.   

Abstract

Importance: In young febrile infants, serious bacterial infections (SBIs), including urinary tract infections, bacteremia, and meningitis, may lead to dangerous complications. However, lumbar punctures and hospitalizations involve risks and costs. Clinical prediction rules using biomarkers beyond the white blood cell count (WBC) may accurately identify febrile infants at low risk for SBIs. Objective: To derive and validate a prediction rule to identify febrile infants 60 days and younger at low risk for SBIs. Design, Setting, and Participants: Prospective, observational study between March 2011 and May 2013 at 26 emergency departments. Convenience sample of previously healthy febrile infants 60 days and younger who were evaluated for SBIs. Data were analyzed between April 2014 and April 2018. Exposures: Clinical and laboratory data (blood and urine) including patient demographics, fever height and duration, clinical appearance, WBC, absolute neutrophil count (ANC), serum procalcitonin, and urinalysis. We derived and validated a prediction rule based on these variables using binary recursive partitioning analysis. Main Outcomes and Measures: Serious bacterial infection, defined as urinary tract infection, bacteremia, or bacterial meningitis.
Results: We derived the prediction rule on a random sample of 908 infants and validated it on 913 infants (mean age was 36 days, 765 were girls [42%], 781 were white and non-Hispanic [43%], 366 were black [20%], and 535 were Hispanic [29%]). Serious bacterial infections were present in 170 of 1821 infants (9.3%), including 26 (1.4%) with bacteremia, 151 (8.3%) with urinary tract infections, and 10 (0.5%) with bacterial meningitis; 16 (0.9%) had concurrent SBIs. The prediction rule identified infants at low risk of SBI using a negative urinalysis result, an ANC of 4090/µL or less (to convert to ×109 per liter, multiply by 0.001), and serum procalcitonin of 1.71 ng/mL or less. In the validation cohort, the rule sensitivity was 97.7% (95% CI, 91.3-99.6), specificity was 60.0% (95% CI, 56.6-63.3), negative predictive value was 99.6% (95% CI, 98.4-99.9), and negative likelihood ratio was 0.04 (95% CI, 0.01-0.15). One infant with bacteremia and 2 infants with urinary tract infections were misclassified. No patients with bacterial meningitis were missed by the rule. The rule performance was nearly identical when the outcome was restricted to bacteremia and/or bacterial meningitis, missing the same infant with bacteremia. Conclusions and Relevance: We derived and validated an accurate prediction rule to identify febrile infants 60 days and younger at low risk for SBIs using the urinalysis, ANC, and procalcitonin levels. Once further validated on an independent cohort, clinical application of the rule has the potential to decrease unnecessary lumbar punctures, antibiotic administration, and hospitalizations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30776077      PMCID: PMC6450281          DOI: 10.1001/jamapediatrics.2018.5501

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  47 in total

1.  Evaluation for Neonatal HSV in Infants Undergoing Workup for Serious Bacterial Infection: A 5-Year Retrospective Review.

Authors:  Laura H Brower; Paria M Wilson; Eileen Murtagh-Kurowski; Joshua D Courter; Samir S Shah; Amanda C Schondelmeyer
Journal:  Hosp Pediatr       Date:  2020-05-08

2.  Physicians' and Nurses' Perspectives on the Decision to Perform Lumbar Punctures on Febrile Infants ≤8 Weeks Old.

Authors:  Paul L Aronson; Paula Schaeffer; Liana Fraenkel; Eugene D Shapiro; Linda M Niccolai
Journal:  Hosp Pediatr       Date:  2019-06

3.  Febrile Infants ≤60 Days Old With Positive Urinalysis Results and Invasive Bacterial Infections.

Authors:  Lyubina C Yankova; Mark I Neuman; Marie E Wang; Christopher Woll; Adrienne G DePorre; Sanyukta Desai; Laura F Sartori; Lise E Nigrovic; Christopher M Pruitt; Richard D Marble; Rianna C Leazer; Sahar N Rooholamini; Fran Balamuth; Paul L Aronson
Journal:  Hosp Pediatr       Date:  2020-12

4.  Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.

Authors:  Kaitlin Widmer; Sarah Schmidt; Leigh Anne Bakel; Michael Cookson; Jan Leonard; Amy Tyler
Journal:  Hosp Pediatr       Date:  2021-03

5.  A Descriptive Analysis of the Cumulative Experiences of Emergency Medicine Residents in the Pediatric Emergency Department.

Authors:  Kirsten V Loftus; Daniel J Schumacher; Matthew R Mittiga; Erin McDonough; Brad Sobolewski
Journal:  AEM Educ Train       Date:  2020-06-25

6.  Characteristics of Afebrile Infants ≤60 Days of Age With Invasive Bacterial Infections.

Authors:  Marie E Wang; Mark I Neuman; Lise E Nigrovic; Christopher M Pruitt; Sanyukta Desai; Adrienne G DePorre; Laura F Sartori; Richard D Marble; Christopher Woll; Rianna C Leazer; Fran Balamuth; Sahar N Rooholamini; Paul L Aronson
Journal:  Hosp Pediatr       Date:  2020-12-14

7.  Clinical Progress Note: Procalcitonin in the Identification of Invasive Bacterial Infections in Febrile Young Infants.

Authors:  Marie E Wang; Nivedita Srinivas; Russell J McCulloh
Journal:  J Hosp Med       Date:  2021-03       Impact factor: 2.960

8.  Cost Analysis of Emergency Department Criteria for Evaluation of Febrile Infants Ages 29 to 90 Days.

Authors:  Courtney Coyle; Guy Brock; Rebecca Wallihan; Julie C Leonard
Journal:  J Pediatr       Date:  2020-10-31       Impact factor: 4.406

9.  Parents' Perspectives on Communication and Shared Decision Making for Febrile Infants ≤60 Days Old.

Authors:  Paul L Aronson; Paula Schaeffer; Linda M Niccolai; Eugene D Shapiro; Liana Fraenkel
Journal:  Pediatr Emerg Care       Date:  2021-12-01       Impact factor: 1.454

10.  Development of an App to Facilitate Communication and Shared Decision-making With Parents of Febrile Infants ≤ 60 Days Old.

Authors:  Paul L Aronson; Mary C Politi; Paula Schaeffer; Eduardo Fleischer; Eugene D Shapiro; Linda M Niccolai; Elizabeth R Alpern; Steven L Bernstein; Liana Fraenkel
Journal:  Acad Emerg Med       Date:  2020-09-09       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.